VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (”Almaden” or ”the Company”; TSX: AMM; AAUAF) is pleased to ann
VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) is pleased to...
VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or the “Company”; TSX: AMM; OTCQB: AAUAF) is pleased to announce th…
VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (together with its Mexican Subsidiary, Minera Gorrión S.A. de C.V.,...
NOTICE OF NO AUDITOR REVIEW OF CONDENSED
CONSOLIDATED INTERIM FINANCIAL STATEMENTS
The accompanying unaudited condensed consolidated interim financial statements...
Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares rose 90.3% to $2.36 in pre-market trading after dropping over 7% on Monday. YS Biopharma's PIKA Rabies Vaccine recently received Phase 3 clinical trial approval from Philippines FDA.
Consolidated Financial Statements of
Almaden Minerals Ltd.
For the years ended December 31, 2022, 2021 and 2020
Almaden Minerals Ltd.
... | March 24, 2023